Maternal circulating biomarkers associated with placenta accreta spectrum disorders

作     者：Zhirong Guo Huixia Yang Jingmei Ma 

作者机构：Department of Obstetrics and GynecologyPeking University First HospitalBeijing 100034China Beijing Key Laboratory of Maternal Fetal Medicine of Gestational Diabetes MellitusBeijing 100034China 

出 版 物：《Chinese Medical Journal》 (中华医学杂志（英文版）)

年 卷 期：2023年第136卷第8期

页      面：995-997页

核心收录：

学科分类：1002[医学-临床医学] 100211[医学-妇产科学] 10[医学] 

基　　金：Strategic Collaborative Research Program of the Ferring Institute of Reproductive Medicine(No.FIRMA 181104) National Key Research and Development Program of China(No.2021YFC2700700) 

主　　题：bladder disorders spectrum 

摘      要：To the Editor:Placenta accreta spectrum(PAS)disorders refer to a spectrum of abnormal *** subtypes include placenta accreta(creta or adherenta,PA),placenta increta(PI),and placenta percreta(PP).The incidence of PAS has dramatically increased over the past four decades.A study using a nationally representative sample in the United States showed that the prevalence of PAS was 0.29%among women who underwent cesarean delivery with live birth.[1]Women with PAS are at a considerably higher risk of concurrent hemorrhage,bladder and urinary tract injury,and hysterectomy during delivery.[1]